Research

Do You Have All The Data You Want?

Trivariate’s database includes hundreds of pieces of information each day on each stock back for 25 years.   We regularly look at and create custom dashboards for investors, and would encourage you to click on the attached spreadsheets and let us know what data you would like to see – and what sector you care about

Read More »

Level Set – Opposite Day Only Works At Extremes

Years ago, when we were working at Morgan Stanley, we wrote about how we had a growing feeling that any short-term bad news on the economy was going to be subsequently good for stocks, and any incrementally good news on the economy was likely to cause a market sell-off. We titled the work “Bad Is

Read More »

Do You Care About Healthcare Stocks?

The Healthcare sector has lagged year-to-date. Dispersion of returns has also been narrow, with 3-month forward return dispersion only lower in February of 2010 and April of 2018. Source: Trivariate Research Generalist investors are asking questions like: Will Pharmaceuticals be defensive in a market correction? Will the lower earnings estimate forecasts that have been reduced due

Read More »

If You’re a Stock Picker Look at Staples

Over the last few weeks, there have been some mixed macro datapoints, driving bond yields lower.  While the economy appears to be more likely to erode than recover, it is also possible that short-term cyclical inflation could exacerbate the issue. We analyzed 95 years of data and found that Consumer Staples typically do well during

Read More »

Why Technology Investing Is Getting Riskier

Every portfolio manager tells their potential investors that they buy quality stocks. Growth portfolio managers sometimes have various marketing names for this group – from disruptors, to compounders — but in the end, they market to their partners that they own quality stocks. Quality is a big piece of the index: Trivariate has a proprietary

Read More »

Level Set – How Should Growth Managers Protect Capital?

Over the last 25 years there have been twenty sell-offs in the growth stock universe of 10% or more. An incrementally hawkish Fed, growing fears of stagflation, a slowdown in the US consumer, a pause in I.T. spend from increasingly cautious CEOs, a disappointing recovery in China, crowded positioning, accelerating 2H of 2024 earnings estimates

Read More »

The Blow-Up Playbook

During earnings season, about 1 in 13 Technology stocks trades down 15% or more on results.   Last quarter we saw the highest percentage of “blow-ups” in a decade.  With so much quantitative money entering the market after earnings, some of these blow-ups become good entry points (or good to immediately cover if an investor was

Read More »

The Ways to Use FCF Yield to Pick Stocks

We remember in 1987, Australian Pat Cash beat Czech star Ivan Lendl in the Wimbledon Gentlemen’s final.  A fan in the crowd famously held up a sign that said “Cash is better than a Czech.” Many investors would agree that cash on the balance sheet is better than an “I.O.U.,” and many also focus on

Read More »

Level Set – What If Stagflation Was a Stock?

If stagflation were a stock, it would be up off of lows. The consensus has rightfully assigned a very low probability of stagflation appearing over the past couple of years. Nominal GDP has been strong, and inflation has peaked and rolled over. But trends are slowly changing. While a slowing economy and stubborn inflation may

Read More »